News20/08/2025
Benchling acquires ReSync Bio and Sphinx Bio teams
Benchling, Inc. →Benchling announced that it had acquired the teams at ReSync Bio and Sphinx Bio to expand AI tools for scientific workflows. The announcement describes a team acquisition, without establishing acquisition of every legal entity or asset.